EPAS1 and renal carcinoma: Bioactive lipids could promote or inhibit the development and metastasis of renal cancer by regulating the stability and transcriptional activity of HIF-2α, thus affecting the proliferation, migration, angiogenesis, immune escape, and other processes of renal cancer cells28, 29.